Cancer immunology. Cancer's bulwark against immune attack: MDS cells.
Marx
Jean
J
D000818:Animals; D001120:Arginine / Q000378:metabolism; D001402:B-Lymphocytes / Q000276:immunology; D019496:Cancer Vaccines / Q000276:immunology / Q000627:therapeutic use; D051546:Cyclooxygenase 2 / Q000378:metabolism; D006801:Humans; D007108:Immune Tolerance; D007249:Inflammation; D053583:Interleukin-1beta / Q000276:immunology / Q000378:metabolism; D008264:Macrophages / Q000276:immunology; D022423:Myeloid Cells / Q000276:immunology* / Q000378:metabolism; D009369:Neoplasms / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D030421:Peroxynitrous Acid / Q000378:metabolism; D011948:Receptors, Antigen, T-Cell / Q000276:immunology / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
D019496:Cancer Vaccines; D053583:Interleukin-1beta; D011948:Receptors, Antigen, T-Cell; D042461:Vascular Endothelial Growth Factor A; D030421:Peroxynitrous Acid; D001120:Arginine; D051546:Cyclooxygenase 2